The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / 3•••• H••••••••• S••••

The Rohatyn Group Completes Sale of 3•••• H••••••••• S•••• to A•••••• P•••••••••

Exit to a strategic buyerclosedannounced Nov 20, 2014closed Nov 20, 2014Fact
What happened
Target
3•••• H••••••••• S••••
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
healthcare / pharma
Target location
unknown
Seller kind
Sponsor
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
3 named
Buy side
Sell side
  • T•• M••••••••• L•Sellerconfirmed
    “The Rohatyn Group (“TRG”), a global asset manager specializing in emerging markets and real assets, today announced that TRG Growth Fund II has finalised the sale of its 36.6% shareholding in H••••••••• AD to A•••••• P••••••••• OOD, a company controlled by the Domuschiev family. | published on TRG's”
Side not stated
Evidence
“The Rohatyn Group Completes Sale of 3•••• H••••••••• S•••• to A•••••• P•••••••••”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026
The Rohatyn Group Completes Sale of 3•••• H••••••••• S•••• to A•••••• P••••••••• | Private Equity Intelligence | DFX